期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 283, 期 44, 页码 29671-29680出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M802785200
关键词
-
资金
- National Natural Science Foundation of China [30371580, 30572109]
- Shanghai Science and Technology Committee [03J14019, 06DJ14004, 06DZ19504]
- Cancer Hospital/Cancer Institute of Fudan University [YJ200604]
- Shanghai Pujiang Program
- [2006CB0D0901]
BRCA2 is closely related to the pathogenesis of breast cancer. In the present study, we found that estrogen can activate BRCA2 transcription, which is estrogen receptor (ER) alpha-dependent. During estrogen treatment, ER alpha interacted with CREB-binding protein/p300, p68/p72, and MyoD and formed an activating transcriptional complex that could bind to many Sp1 sites on the BRCA2 promoter and activate its transcription by inducing histone acetylations. MyoD is a new component of ER alpha complex. ER beta or p53 attenuated ER alpha-mediated transcriptional activation by preventing the recruitment of ER alpha transcriptional complex and histone acetylations on the BRCA2 promoter. ER beta interacted with ER alpha and CREB-binding protein/p300 and formed a weak activating transcriptional complex that competed for binding to Sp1 sites with ER alpha transcriptional complex and slightly attenuated BRCA2 transcription. Different from ER beta, p53 interacted with HDAC1 and CtBP1 and formed an inhibiting transcriptional complex that could compete for binding to Sp1 sites with ER alpha transcriptional complex and inhibit BRCA2 transcription more significantly.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据